HDAC11 and carcinoma: HDAC11 is reported to be overexpressed in several carcinomas, and HDAC11 depletion causes cell death and inhibits metabolic activity in controlling proliferation in several human carcinoma cell lines (colon, prostate, ovarian cell lines) (Deubzer et al., 2013).